21.2.2001 Official Journal of the European Communities L 50/23 COMMISSION DECISION of 20 February 2001 for the implementation of a bluetongue vaccination programme in certain parts of the protection zone in Italy and the purchase by the Community of vaccine for this purpose (notified under document number C(2001) 424) (Only the Italian text is authentic) (2001/141/EC) THE COMMISSION OF THE EUROPEAN COMMUNITIES, (8)  The financial contribution from the Community shall be Having regard to the Treaty establishing the European Community, Having regard to Council Directive 2000/75/EC of 20 November 2000 (") laying down specific provisions for the control and eradiction of bluetongue, and in particular Article 9(2), Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field (?), as last amended by Council Decision 2000/12/EC (}), and in particular Article 3(3) and (5), Whereas: (1)  During the year 2000 bluetongue outbreaks were noti- fied in different Italian regions: Sardinia, Sicily and Calabria. (2)  Italian authorities informed the Commission on the 19 December 2000 that they intended to perform in 2001 a vaccination campaign in Calabria and Basilicate regions and in the province of Salerno. (3)  The objective of this campaign is to prevent a spread of the discase on the rest of the territory of the Community by interrupting the virus circulation in the protection zone demarcated around the outbreaks in Calabria. (4)  The amount of vaccine necessary to carry on this campaign is of 1700 000 doses of monovalent blue- tongue vaccine serotype 2. (5)  No bluetongue vaccine is produced by the pharmaceut- ical industry based in the Member States. (6)  The Onderstepoort Laboratory in South Africa is the only laboratory which may produce that type of mono- valent vaccine (attenuated vaccine) with the serotype 2. (7)  Pursuant to Article 3(2) of Council Regulation (EC) No 1258/1999 (%), veterinary and plant health measures undertaken in accordance with Community rules shall be financed under the Guarantee Section of the Euro- pean Agricultural Guidance and Guaranteee Fund. For financial control purposes, Articles 8 and 9 of Council Regulation (CE) No 12581999 apply. 27, 22.12.2000, p. 74. 24, 18.8.1990, p. 19. , 6.1.2001, p. 27. 60, 26.6.1999, p. 103. =W N W granted provided that the actions planned are efficiently carried out and that the authorities supply all the neces- sary information within the time limits laid down. (99  The measures provided for in this Decision are in accordance with the opinion of the Standing Veterinary Commiittee, HAS ADOPTED THIS DECISION: Article 1 Italy will implement in spring 2001 a vaccination programme against bluetonge in Calabria and Basilicate regions and in the Salerno province. Article 2 For the implementation of the programme referred to in Article 1 the financial assistance from the Community will cover the supply to Italy of 1700 000 doses of monovalent vaccine serotype 2. Article 3 The maximum cost of the measures referred to in Article 2 shall be up to EUR 140 000. Atrticle 4 1. For the vaccination programme referred to in Article 1 the Director-General of the Directorate-General for Health and Consumer Protection shall be authorised to make arrangements with Onderstepoort Laboratory in South Africa for the purchase of 1700000 doses of monovalent bluetongue vaccine (serotype 2). 2. The arrangements referred to in paragraph 1 shall include the airfreight to Italy. Atticle 5 The Commission may carry out on-the-spot checks in collab- oration with the competent national authorities to ensure that the programme has been implemented. The Commission shall inform the Member States of the outcome of these checks.